Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
PLoS Negl Trop Dis. 2012;6(2):e1512. doi: 10.1371/journal.pntd.0001512. Epub 2012 Feb 14.

Multiple mutations in heterogeneous miltefosine-resistant Leishmania major population as determined by whole genome sequencing.

Author information

  • 1Centre de Recherche en Infectiologie, Université Laval, Québec, Canada.

Abstract

BACKGROUND:

Miltefosine (MF) is the first oral compound used in the chemotherapy against leishmaniasis. Since the mechanism of action of this drug and the targets of MF in Leishmania are unclear, we generated in a step-by-step manner Leishmania major promastigote mutants highly resistant to MF. Two of the mutants were submitted to a short-read whole genome sequencing for identifying potential genes associated with MF resistance.

METHODS/PRINCIPAL FINDINGS:

Analysis of the genome assemblies revealed several independent point mutations in a P-type ATPase involved in phospholipid translocation. Mutations in two other proteins-pyridoxal kinase and α-adaptin like protein-were also observed in independent mutants. The role of these proteins in the MF resistance was evaluated by gene transfection and gene disruption and both the P-type ATPase and pyridoxal kinase were implicated in MF susceptibility. The study also highlighted that resistance can be highly heterogeneous at the population level with individual clones derived from this population differing both in terms of genotypes but also susceptibility phenotypes.

CONCLUSIONS/SIGNIFICANCE:

Whole genome sequencing was used to pinpoint known and new resistance markers associated with MF resistance in the protozoan parasite Leishmania. The study also demonstrated the polyclonal nature of a resistant population with individual cells with varying susceptibilities and genotypes.

PMID:
22348164
[PubMed - indexed for MEDLINE]
PMCID:
PMC3279362
Free PMC Article

Images from this publication.See all images (6)Free text

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk